Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID. uri icon

authors

  • Calméjane, Louis
  • Guillo, Lucas
  • Serrero, Mélanie
  • Bouguen, Guillaume
  • Nachury, Maria
  • Guillaume Le Cosquer, MD, PhD
  • Roblin, Xavier
  • Abitbol, Vered
  • Hammoudi, Nassim
  • Simon, Marion
  • Fumery, Mathurin
  • Reenaers, Catherine
  • Savoye, Guillaume
  • Benezech, Alban
  • Cavicchi, Maryan
  • Charkaoui, Maeva
  • Buisson, Anthony
  • Caron, Bénédicte
  • Coffin, Benoît
  • Geyl, Sophie
  • Goutorbe, Félix
  • Hupé, Marianne
  • Gay, Claire
  • Vidon, Mathias
  • Laharie, David
  • Kirchgesner, Julien
  • Uzzan, Mathieu
  • Amiot, Aurélien
  • Nuzzo, Alexandre
  • Vuitton, Lucine
  • Atanasiu, Calina
  • Stefanescu, Carmen
  • Altwegg, Romain

publication date

  • April 2026